- Conditions
- Respiratory Distress Syndrome, Pre-term Infants
- Interventions
- APC-0101 (SF-RI 1 surfactant for inhalation combined with a dedicated delivery system), Control
- Combination Product · Other
- Lead sponsor
- Aerogen Pharma Limited
- Industry
- Eligibility
- 1 Hour to 24 Hours
- Enrollment
- 520 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 12
- States / cities
- Little Rock, Arkansas • La Jolla, California • Jacksonville, Florida + 9 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–7
of 7
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Transient Tachypnea of the Newborn
- Interventions
- High Flow Nasal Cannula, Bubble Nasal CPAP
- Other
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- Up to 24 Hours
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- PS Group, NCPAP Group, ISX Group
- Drug · Device
- Lead sponsor
- Vermont Oxford Network
- Network
- Eligibility
- 26 Weeks to 29 Weeks
- Enrollment
- 648 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2011
- U.S. locations
- 1
- States / cities
- Burlington, Vermont
- Conditions
- Respiratory Distress Syndrome in Premature Infant
- Interventions
- AeroFact, nCPAP
- Drug · Other
- Lead sponsor
- Aerogen Pharma Limited
- Industry
- Eligibility
- 26 Weeks to 31 Weeks
- Enrollment
- 261 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 37
- States / cities
- Little Rock, Arkansas • Berkeley, California • Orange, California + 27 more
- Conditions
- Respiratory Insufficiency
- Interventions
- Nasal CPAP, Humidified High Flow Nasal Cannula (HHFNC)
- Other
- Lead sponsor
- University of Utah
- Other
- Eligibility
- Up to 8 Weeks
- Enrollment
- 420 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2012
- U.S. locations
- 8
- States / cities
- Philadelphia, Pennsylvania • Lackland Air Force Base, Texas • Ogden, Utah + 3 more
- Conditions
- Respiratory Distress Syndrome
- Interventions
- Nasal continuous positive airway pressure (nCPAP), Laryngeal Mask Airway (LMA) to deliver surfactant, Surfactants, Pulmonary
- Device · Drug
- Lead sponsor
- University of Minnesota
- Other
- Eligibility
- Up to 36 Hours
- Enrollment
- 103 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 7
- States / cities
- Loma Linda, California • San Diego, California • Maple Grove, Minnesota + 4 more
- Conditions
- Knee Replacement Surgery
- Interventions
- Nasal Continuous Positive Airway Pressure (NCPAP)
- Other
- Lead sponsor
- Pediatrix
- Other
- Eligibility
- 21 Years to 69 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Wilmington, North Carolina